We report 2 primary renal sarcomas demonstrating BCOR-CCNB3 gene fusions that have recently been identified in undifferentiated round cell sarcomas of bone and soft tissue. These neoplasms occurred in male children aged 11 and 12 years, and both were cystic as a result of entrapment and dilatation of native renal tubules. Both cases were composed of variably cellular bland spindle cells with fine chromatin set in myxoid stroma and separated by a branching capillary vasculature. Both neoplasms demonstrated immunoreactivity for BCOR, cyclin D1, TLE1, and SATB2 in the spindle neoplastic cells and negativity in the prominent capillary vasculature. One case was extensively cystic and had hypocellular areas that simulated cystic nephroma; this neoplasm recurred 3 years later as a solid, highly cellular spindle cell sarcoma in the abdominal cavity. The morphology and immunoprofile of these renal neoplasms was compared with a control group of other sarcomas with BCOR genetic abnormalities, including clear cell sarcoma of the kidney (CCSK), infantile undifferentiated round cell sarcomas of soft tissue/primitive myxoid mesenchymal tumor of infancy, and bone/soft tissue sarcomas with BCOR-CCNB3 gene fusion; along with primary renal synovial sarcoma. Our findings show that the renal sarcomas with BCOR-CCNB3 gene fusion overlap with CCSK. These results are in keeping with a "BCORalteration family" of renal and extrarenal neoplasms which includes CCSK and undifferentiated round cell sarcomas of soft tissue/ primitive myxoid mesenchymal tumor of infancy (which typically harbor BCOR internal tandem duplication), and BCOR-CCNB3 sarcomas, all of which are primarily driven by BCOR overexpression and have overlapping (but not identical) clinicopathologic features.
C lear cell sarcoma of the kidney (CCSK) comprises approximately 3% of pediatric renal neoplasms, and occurs at a mean patient age of 3 years. 1, 2 The classic morphologic pattern of CCSK is that of nests or cords of neoplastic cells separated by regularly spaced, arborizing fibrovascular septa. The cord cells can be either round, epithelioid or spindled, and are separated by extracellular mucopolysaccharide that creates a resemblance to clear cytoplasm. The nuclei are round to ovoid with fine chromatin without prominent nucleoli. The septal cells are spindled, fibroblast-like cells that surround thin, regularly branching capillaries, and quite often form cellular perivascular sheaths (cellular septa). CCSK may also display a spectrum of morphologic patterns that mimic other neoplasms, including myxoid, sclerosing, cellular, spindled, storiform, palisaded, trabecular, and epithelioid patterns. While cyclin D1 3, 4 and SATB2 5 are often immunoreactive in CCSK, most other immunohistochemical markers such as CD34, S100, desmin, CD99, and cytokeratin are negative.
As implied by its name, CCSK has long been thought to be a kidney-specific sarcoma, with only rare putative extrarenal CCSK-like neoplasms reported. 1 Long a mystery, genetic alterations underlying CCSK have been delineated in the past decade. The majority ( > 90%) of CCSK harbor internal tandem duplications (ITD) in the last exon of the BCOR (Bcl6 interacting co-repressor) gene, which in CCSK is thought to regulate gene transcription through an epigenetic silencing mechanism. [6] [7] [8] A smaller subset of CCSK harbor a YWHAE-NUTM2B/E gene fusion resulting from a t(10;17)(q22.3;p13.3) translocation which is identical to that seen in high grade endometrial stromal sarcoma. 9, 10 These 2 genetic alterations in CCSK appear to be mutually exclusive. 11, 12 A small subset of otherwise typical CCSK (< 10%) lack either alteration. 11 In the past 5 years, upregulation of BCOR by similar mechanisms as found in CCSK has been identified as an underlying genetic alteration in several soft tissue sarcomas of young patients. First, BCOR ITD and the YWHAE-NUTM2B/E gene fusion have been identified in undifferentiated round cell sarcoma (URCS) and primitive myxoid mesenchymal tumor of infancy (PMMTI), 2 neoplasms that typically affect children under the age of 1 year. 5, 13, 14 On careful morphologic review, the latter 2 neoplasms overlap significantly morphologically with CCSK. 14 Second, a BCOR-CCNB3 gene fusion resulting from an X chromosomal paracentric inversion has been identified in previously unclassified soft tissue and bone sarcomas which typically affect teenagers and young adults with a male predominance. [15] [16] [17] [18] While the majority of these BCOR-CCNB3 sarcomas were identified among EWSR1-negative Ewing sarcomas and thought to be primarily small round neoplasms, 15, 16 more recently cases with spindled morphology have been described. 17, 18 Importantly, high levels BCOR mRNA expression resulting in BCOR protein overexpression as detected by immunohistochemistry (IHC) 5 and a distinctive BCOR-driven transcriptional profile 14 have been identified in URCS/PMMTI, BCOR-CCNB3 fusion-positive sarcomas, and CCSK, suggesting that all of these neoplasms are highly genetically related. However, the existence of BCOR-CCNB3 sarcomas originating in the kidney as well as a relationship between bone/soft tissue sarcomas with the BCOR-CCNB3 fusion and CCSK has not previously been described.
In this report, we describe 2 primary renal sarcomas harboring BCOR-CCNB3 gene fusions. We review the morphology and perform a broad immunochemical analysis of these neoplasms, and compare them with control groups of typical CCSK, BCOR-CCNB3-positive bone/soft tissue sarcoma, and BCOR-ITD positive URCS/PMMTI. Review of the morphology and immunohistochemical profile of BCOR-CCNB3-positive renal and bone/soft tissue sarcomas demonstrates overlap with CCSK. Finally, given prior work demonstrating upregulation of BCOR identified in approximately 50% of soft tissue synovial sarcomas, we examine the expression of BCOR and related markers in primary renal synovial sarcoma, 19 which represents the main differential diagnosis of the BCOR-CCNB3 renal sarcomas.
METHODS

Cases
Both renal sarcomas with BCOR-CCNB3 gene fusion were identified in a review of renal sarcomas in our files with overlapping features of CCSK and renal synovial sarcoma. Both of these neoplasms had been considered unclassified at the time of diagnosis. All of the cases in the review cohort were screened by IHC by BCOR, and positively labeling cases were analyzed for the presence of BCOR and CCNB3 fusion/inversion by fluorescence in situ hybridization (FISH). Break-apart FISH was also performed with custom BAC probes for the following genes: SS18, SSX1, SSX2, SS18L1 (all for synovial sarcoma), or YWHAE (for CCSK) using previously described methodology. 20 BCOR and CCNB3 FISH probes utilized are listed in Supplementary Table 1 (Supplemental Digital Content 1, http://links.lww. com/PAS/A534). SSX1, SSX2, SS18, and SS18L1 probes utilized have been described previously. 20 
Review of a Control Group of BCOR-associated Soft Tissue Sarcomas
Following identification of renal sarcomas with BCOR-CCNB3 gene fusions, we reviewed the morphologic and immunohistochemical features of a cohort of 20 URCS/PMMTI (all showing BCOR ITD) and 3 other cases demonstrating the YWHAE-NUTM2B/E fusion from the files of one author (C.R.A.), most of them included in previous publications. 5, 14 All but one of these neoplasms had accompanying BCOR IHC for evaluation. We also reviewed 24 cases of genetically confirmed BCOR-CCNB3 bone and soft tissue sarcomas from the files of one author (C.R.A.). Twelve of these cases had accompanying BCOR IHC.
Primary Renal Synovial Sarcoma Control Group
We identified 7 genetically confirmed primary renal synovial sarcomas from our files, all of which demonstrated SS18 rearrangements by FISH. These cases occurred in 5 males and 2 females. These patients ranged in age from 35 to 66 years (mean age: 49 y; median age: 48.5 y). Of cases with known fusion partner, 3 of 4 were SSX2 while one was SSX1, consistent with the previously reported distribution of gene fusions found in primary renal synovial sarcoma. 21 
CCSK Control Group
We identified 9 CCSK from the files of one author (P.A.). These cases occurred in 6 males and 3 females, and ranged in age from 6 to 42 months (mean: 24 mo; median: 19 mo). All 9 of these cases demonstrated strong nuclear labeling for BCOR by IHC. Of the 5 cases studied genetically, 4 demonstrated BCOR ITD, while one demonstrated the YWHAE-NUTM2B gene fusion.
IHC was performed as previously described 1, 5, 14, 19 for the following proteins on the BCOR-CCNB3 renal sarcomas: BCOR, SATB2, TLE1, Bcl2, CD56, CD99, CD10, desmin, S100, cytokeratin AE1/3 and, cyclin D1. IHC for selected markers from this group were also performed on cases in the control groups.
RESULTS
Case Reports
Case 1 was an 11-year-old male who presented with a 27 cm cystic renal neoplasm which was treated by radical nephrectomy. The nephrectomy specimen weighed 1845 g and no further follow-up is available.
Case 2 was a 12-year-old male who presented with a 13 cm solid and cystic renal neoplasm which was treated by radical nephrectomy. Fifteen months later, the patient developed an abdominal mass which represented a recurrence of the prior neoplasm.
In both cases, the primary renal neoplasm was extensively cystic, with the cysts being lined by non-neoplastic, dilated native renal tubules. The cyst walls were variably cellular in both cases. In many areas of case 1, the cyst walls were composed of nondescript, nonpleomorphic, bland spindle cells which condensed beneath the cyst epithelium, creating a "cambium-like" appearance. In other areas, these cells became more plump and epithelioid, and alternated with prominent perivascular spindle cells in a pattern reminiscent of the biphasic cord cell-septal pattern of CCSK. The more epithelioid cell nuclei were bland, and had fine, open chromatin similar to that of CCSK (Fig. 1) .
In case 2, the cystic primary renal neoplasm was extremely bland. The cyst walls were hypocellular and composed predominantly of uniform spindle cells with minimal cytoplasm, creating a resemblance to cystic nephroma or mixed epithelial stromal tumor. Focally, the cyst walls were slightly more cellular, and one could appreciate a biphasic cord cell/septal cell pattern that suggested CCSK. The neoplastic cells in the cyst walls were nonpleomorphic and lacked mitotic activity (Fig. 2) . The abdominal recurrence of this neoplasm, in contrast, demonstrated solid fascicles of cellular, nonpleomorphic spindle cells with frequent mitotic figures.
Both cases demonstrate similar immunohistochemical profiles; therefore, they are discussed together. In both cases, the neoplasm demonstrated strong and diffuse nuclear labeling for BCOR. Importantly, BCOR IHC highlighted the biphasic pattern of these lesions, with strong nuclear labeling of the "cord cells" and absence of labeling in the prominent admixed "septal cells," similar to the pattern previously described in CCSK (Figs. 1E, 2E ). 5 As suggested by the morphology, the BCOR immunoreactive cells were less frequent and focally absent in the bland, hypocellular cyst walls of the primary cystic renal neoplasm in case 2, but comprised the majority of the cells in the solid, high grade spindle cell recurrence of that lesion (Fig. 2H ). Both neoplasms also demonstrated diffuse immunoreactivity for Bcl2, CD56, SATB2, cyclin D1, and TLE1 (Figs. 1H, 2F) . Desmin, S100 protein, cytokeratin AE1/3, and CD34 were negative in both cases. PAX8 was negative in both the primary and recurrent tumor in case 2 (native renal tubules in the primary were PAX8 + , providing a positive internal control). In case 1, there was focal weak nuclear staining of the more epithelioid "cord cells," but this was less intense than that of the entrapped native renal tubules that provided an internal control (Fig. 1G) .
FISH demonstrated an inversion-fusion pattern between BCOR and CCNB3 in both cases, including both the bland cystic primary renal neoplasm in case 2 and its high grade abdominal recurrence (Fig. 3) .
Review of the Control Group of BCOR-related Soft Tissue Sarcomas
The control group of 23 URCS/PMMTI soft tissue cases with either BCOR ITD or YWHAE fusions occurred in patients ranging from ages 2 weeks to 14 months. As previously described, these neoplasms overlap significantly with CCSK, in that they featured bland round, epithelioid to spindled "cord cells" with open chromatin and prominent "septal cells." 14 There was strong nuclear labeling for BCOR in 21 of the 22 cases in which IHC was available. Importantly, the BCOR IHC highlighted the "cord cells" but not the "septal cells," similar to the pattern noted in renal CCSK as previously noted. 5 Also of note, 1 case was predominantly composed of a high grade spindle cell component more typical of the BCOR-CCNB3 sarcomas, while focal areas of spindling were noted in one third of cases. 14 The 24 BCOR-CCNB3 bone and soft tissue sarcomas occurred in patients ranging in age from 2 years to 24 years. On review, all demonstrated undifferentiated round to spindle cell features that resembled the cellular spindle pattern of CCSK, 1 in which the "cord cells" acquire a more spindled appearance that resembles monophasic spindle cell synovial sarcoma. 1 BCOR IHC highlighted the prominent labeling of "cord cells" and absence of labeling in the prominent "septal cell" component, as previously demonstrated in CCSK, 5 in all 12 cases in which it was performed (Fig. 4) . Also of note, a subset of bone/soft tissue cases with the BCOR-CCNB3 fusion demonstrated focally low grade myxoid areas which overlapped with URCS/ PMMTI and the myxoid, hypocellular pattern of CCSK.
Of note, in one case PAX8 IHC had been performed in a primary soft tissue BCOR-CCNB3 sarcoma, and demonstrated weak labeling in cord cells similar to that seen in renal BCOR-CCNB3 case 1 (Fig. 4G) .
Six of 7 BCOR-CCNB3 bone/soft tissue sarcomas and all 4 URCS/PMMTI tested were immunoreactive for cyclin D1. Seven of 9 BCOR-ITD URCS/PMMTI and 5 of 9 soft tissue BCOR-CCNB3 sarcomas were immunoreactive for CD99, though typically in a diffuse cytoplasmic pattern rather than a strong membranous distribution. Both BCOR-CCNB3-positive bone/soft tissue sarcomas tested demonstrated immunoreactivity for TLE1.
CCSK (Control Group)
All 9 CCSK cases demonstrated typical morphologic features, specifically cord cells with fine chromatin and indistinct cytoplasm set in a myxoid stroma and separated by a regular branching capillary vasculature lined by septal cells. All 9 cases demonstrated strong diffuse nuclear labeling for BCOR in the cord cells. As expected from prior literature, 3 of 7 cases studied (42%) demonstrated diffuse nuclear labeling for SATB2, and all 5 tested showed diffuse nuclear labeling for cyclin D1. Four of 5 tested cases demonstrated strong diffuse nuclear labeling for TLE1, as marker not previously studied in CCSK (Fig. 5 ). One of 5 tested CCSK demonstrated strong, diffuse labeling for PAX8 (Fig. 6 ).
Primary Renal Synovial Sarcoma (Control Group)
The 7 genetically confirmed primary renal synovial sarcomas were composed of cellular nonpleomorphic spindle cells associated with dilated native renal tubules in 4 cases, typical of monophasic spindle cell synovial sarcoma arising in the kidney. 19 Of these 7 cases, 4 demonstrated nuclear immunoreactivity for BCOR (58%). As expected, 4 of 5 cases tested demonstrated strong diffuse nuclear labeling for TLE1, while 3 of 5 cases tested were positive for cyclin D1. Two of 5 cases tested demonstrated focal weak/ equivocal staining for SATB2; the other 3 were completely negative.
DISCUSSION
We report 2 primary renal sarcomas demonstrating BCOR-CCNB3 gene fusion. In the absence of molecular findings, these cases were originally considered to be unclassified sarcomas with a differential diagnosis including CCSK and primary renal synovial sarcoma. As neoplasms with BCOR-CCNB3 gene fusion, similar to sarcomas with BCOR-ITD, are associated with a BCOR-driven transcriptional profile, we interrogated the possible relationship of these neoplasms to CCSK. These cases were somewhat unusual for CCSK, in that they affected slightly older children (ages 11 and 12 y) compared with the mean CCSK age of 3, demonstrated predominant spindle morphology, and were associated with extensive dilation of native renal tubules resulting in extensive cystic change. In one case, the combination of hypocellular neoplastic cells within the septa and extensive cystic change created a mimic of a benign mixed epithelial stromal tumor or cystic nephroma. However, while somewhat unusual, the BCOR-CCNB3 renal sarcomas are certainly compatible with CCSK. The patient ages of the BCOR-CCNB3 renal sarcomas are well within the spectrum of CCSK, which in the largest study in the literature (351 cases) occurred in an age range of 2 months to 14 years. 1 Predominant spindle cell morphology and extensive cystic change mimicking cystic nephroma, as classically seen in renal synovial sarcoma, have also previously been described and illustrated in CCSK. 1 We found that the BCOR-CCNB3 renal sarcomas expressed TLE1, a sensitive marker of synovial sarcoma 22,23 which had not previously been studied in CCSK: however, we found that TLE1 was also positive in the typical CCSK in our control group. Both BCOR-CCNB3 renal sarcomas labeled for BCOR, cyclin D1, and SATB2 which are recognized markers of CCSK. Overall, taking together the common morphologic features of these neoplasms including the biphasic BCOR-immunopositive cord cells and BCOR-immunonegative septal cells, along with the immunoreactivity for cyclin D1, TLE1, and SATB2 in the cord cells in the absence of labeling for CD99, desmin, cytokeratin, S100, and CD34, the pathologic features fall within the broad spectrum of CCSK.
Despite their common transcriptional profile driven by a consistent upregulation of BCOR mRNA expression, some differences exist between soft tissue URCS/PMMTI, which harbors BCOR ITD, and BCOR-CCNB3 bone and soft tissue sarcomas. First, CCNB3 overexpression both at the mRNA 5, 14 and protein 15 levels is seen only in BCOR-CCNB3 bone/soft tissue sarcomas and not in URCS/ PMMTI with BCOR ITD. Second, the age at presentation is different; URCS/PMMTI almost overwhelmingly occur in infants, while BCOR-CCNB3 soft tissue sarcomas typically affect teenagers and young adults. Third, most URCS/PMMTI have a heterogeneous appearance with alternating compact round cellular areas with hypocellular myxoid components, whereas BCOR-CCNB3 sarcomas are uniformly highly cellular, rounded and often spindled neoplasms which overlap with Ewing sarcoma and synovial sarcoma. Despite these differences, our review of a large series of URCS/PMMTI and BCOR-CCNB3 sarcomas of bone and soft tissue found significant areas of overlap. Specifically, PMMTI-like areas can be seen at the edge of BCOR-CCNB3 undifferentiated sarcomas of bone and soft tissue, and URCS/PMMTI often have higher grade areas that overlap with BCOR-CCNB3 sarcomas. Previous studies from our group have highlighted morphologic similarities between the URCS/ PMMTI harboring BCOR ITD and CCSK. 5 In this study, we note the similarity of BCOR-CCNB3 sarcomas of bone/soft tissue and kidney with CCSK. This is highlighted by presence of cellular septa within the BCOR-CCNB3 soft tissue sarcomas which are very similar to those seen within CCSK. In both instances, the cellular septa do not label for BCOR, suggesting that these cellular septa represent a florid pericyte-rich reactive proliferations associated with these BCOR-CCNB3 driven neoplasms. Hence, just as in soft tissue where the BCOR-CCNB3 sarcomas overlap with the URCS/PMMTI with BCOR ITD, the primary renal sarcomas with the BCOR-CCNB3 gene fusion overlap with CCSK showing BCOR ITD (Table 1) . We feel that minor differences between CCSK and the BCOR-CCNB3 renal sarcomas are less significant than their unifying features. However, greater experience with the clinicopathologic features and response to therapy of the BCOR-CCNB3 renal sarcomas are needed to further establish this link. We note that a single neoplasm with the BCOR-CCNB3 gene fusion was recently reported in abstract form within a series reported as CCSK. 27 We propose that CCSK, URCS/PMMTI, and BCOR-CCNB3 sarcomas of kidney and bone/soft tissue can be thought of as a "BCOR-alteration family" of renal and extrarenal neoplasms with a common genetic signature and overlapping (but not identical) clinicopathologic features ( Table 2) .
The focal PAX8 labeling of BCOR-CCNB3 renal sarcoma case 1 might be considered unusual for CCSK, which has previously been considered negative for PAX8 though PAX2 labeling has been reported. 28 However, we found that PAX8 is positive in a minority of CCSK, and can be focally expressed in bone/soft tissue BCOR-CCNB3 sarcomas. Furthermore, a recent study found that PAX8 is expressed in over 50% of BCOR-CCNB3 soft tissue sarcomas, 24 and PAX8 immunoreactivity also been described in primitive round cell sarcomas such as alveolar rhabdomyosarcoma and rhabdoid tumor. 28 Hence, in the setting of primitive round/spindle cell neoplasms, PAX8 is not specific for renal parenchymal versus mesenchymal origin.
The predominantly spindle appearance of the BCOR-CCNB3 renal sarcomas created significant overlap with synovial sarcoma, which was the main differential diagnosis for these cases. Morphologic and immunohistochemical overlap of BCOR-CCNB3 soft tissue sarcomas with synovial sarcoma has been reported, 29 as has overlap between CCSK and renal synovial sarcoma. 30 Along these lines, BCOR overexpression has been demonstrated in approximately half (49%) of soft tissue synovial sarcomas, 5 though BCOR expression had not been addressed in primary renal synovial sarcomas until now. In this study, we document that primary renal synovial sarcomas similarly overexpress BCOR in approximately half (60%) of cases. Primary renal synovial sarcomas also express cyclin D1, a sensitive marker of CCSK, and TLE1, a sensitive marker of soft tissue synovial sarcoma, furthering the potential overlap with BCOR-CCNB3 renal sarcoma. As suspected based on previously reported expression profiling and immunohistochemical analysis of soft tissue synovial sarcoma, 5 SATB2 is less frequently expressed in renal synovial sarcoma than in typical CCSK or the renal BCOR-CCNB3 sarcomas, providing one useful discriminatory immunohistochemical marker. While analysis of BCOR gene status and the SS18-SSX gene fusions typically resolve the differential diagnosis of CCSK and renal synovial sarcoma, there may also be significant overlap at the genetic level. Along these lines, a case of a poorly differentiated synovial sarcoma with a variant SS18L1-SSX1 gene fusion and complex rearrangements affecting the Xp11.22-4 region including disruption of BCOR and upregulation of BCOR protein has been reported. 20 Our finding of overlap between BCOR-CCNB3 fusion-positive sarcomas of the kidney and bone/soft tissue with CCSK has potential therapeutic implications. BCOR-CCNB3 sarcomas of bone and soft tissues were initially recognized as a subset of EWS-nonrearranged "Ewing sarcomas," and have historically been treated with Ewing sarcoma chemotherapy regimens, though some evidence exists that their behavior may be more indolent. 17 As such, BCOR-CCNB3 sarcomas are typically treated as Ewing sarcomas at most centers today. Given the overlapping morphology of BCOR-CCNB3 sarcomas with CCSK and their overlapping transcriptional profile, and given that patients with CCSK have been shown to benefit from specific doxorubicin-based chemotherapy, 1, 31 it seems logical to consider treating the BCOR-CCNB3 bone/soft tissue sarcomas with CCSKbased therapy regimens (which emphasize Doxorubicin and do not include Ifosfamide) rather than Ewing sarcoma-based regimens (which include both Doxorubicin and Ifosfamide). The former chemotherapy regimen is overall less toxic, and at least in CCSK has demonstrated significant clinical benefit. Along these lines, PMMTI have recently shown response to therapy similar to that used for CCSK. 32 In summary, we report 2 primary renal sarcomas with the BCOR-CCNB3 gene fusion. We demonstrate that while some features are unusual for CCSK, these neoplasms do overlap with CCSK at the morphologic, immunohistochemical, and genetic level. BCOR-CCNB3 renal sarcomas may account for a subset of cases currently classified as CCSK but which lack BCOR-ITD or YWHAE-NUTM2B/E gene fusions. Our findings support the concept of a BCOR-alteration family of renal and extrarenal neoplasms having a highly related genetic profile and similar (though not identical) clinicopathologic features, including CCSK, BCOR-CCNB3 sarcomas, and URCS/PMMTI. 24 1/1 BCOR-CCNB3 soft tissue sarcoma in the current study was focally positive for PAX8. †Data from Karafin et al. 25 ‡Includes data from Kao et al. 5 §Includes data from Mirkovic et al 3 and Jet Aw et al. 4 ∥Data from Yamada et al. 26 2/2 BCOR-CCNB3 soft tissue sarcomas in the current study were positive for TLE1. NA indicates not available. 
